InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Miller-Rich Nancy, 董事. Officer active across 2 companies, notably Intercept Pharmaceuticals, INC.. In total, 5 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €4k. History available since 27 May 2021. The latest transaction was filed on 3 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Miller-Rich Nancy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
413 股@ US$12.81100.0% 占其流量Common StockSEC:0000950170-24-116048:0
标准退出：2021年8月1日 (T+90)
22,304 股@ US$19.00100.0% 占其流量Common StockSEC:0001104659-23-117105:0
8,111 股0Common StockSEC:0001104659-23-064840:0
7,737 股0Common StockSEC:0001104659-22-065906:0
7,029 股0Common StockSEC:0001104659-21-075220:0
5 条申报中的 5 条
About Miller-Rich Nancy
Nancy Miller-Rich is a Board Member at INTERCEPT PHARMACEUTICALS, INC. She brings valuable expertise in the pharmaceutical field, actively participating in the governance and strategy of the company. Her role is crucial in guiding the organization through its research and development initiatives.
